Not just COVID vaccine, Remdesivir too in short supply in several states

There were reports of shortage of Remdesivir that is used to treat COVID patients, in Maharashtra, Gujarat, Karnataka and Madhya Pradesh.

Published: 10th April 2021 05:23 AM  |   Last Updated: 10th April 2021 08:32 AM   |  A+A-



By Express News Service

MUMBAI/JAIPUR/BHOPAL/BENGALURU: Amid states grappling with stretched Covid facilities and vaccine shortage, Rajasthan and Andhra Pradesh chief ministers sent SOS to the Centre regarding vaccine supply on Friday, even as more inoculation centres were shut in Maharashtra, taking their total count to 592.

There were also reports of shortage of Remdesivir that is used to treat Covid patients, in Maharashtra, Gujarat, Karnataka and Madhya Pradesh.

Seventy-five of the 120 centres across Mumbai, including a jumbo facility in the Bandra Kurla Complex that was inoculating 4,000 people daily, halted vaccinating people on Friday as supply dried up.

EDITORIAL: Full lockdown not feasible, mandatory vaccination needed

“We have been asking the Centre to ramp up the supply, but there is no positive response. To set up a centre, we spend a lot of money on infrastructure and engage many trained people. Shutting down the centres is a big setback to our vaccination drive,” said a senior health official in Maharashtra.

In Rajasthan, the vaccine stock will last only two days, Chief Minister Ashok Gehlot said in a letter to Prime Minister Narendra Modi, and sought immediate supply of 30 lakh doses to ensure smooth continuation of the inoculation drive, particularly during the ‘tika utsav’ proposed by the PM.

ALSO READ: ‘Fine’ for now but if COVID spreads, night curfew is on the way in TN

With hospital beds filling up and demand for oxygen growing, supply is drying up in some states. Maharashtra CM Uddhav Thackeray has already stated that the state is in “dire need” of oxygen of 1,700-2,500 MT oxygen by April-end. 

Long queues at pharmacies for Remdesivir

In Madhya Pradesh, there were reports about deaths of Covid patients due to lack of oxygen at government hospitals in Sagar, Ujjain and Khargone, though the State government denied it. As for Remdesivir, Maharashtra Chief Minister Uddhav Thackeray expects a demand in his state of 90,000 to 1 lakh vials by the end of April while the current stock is 50,000 to 60,000 vials.

In Gujarat, cities like Ahmadabad had people lining up before the medical stores for Remdesivir, as the injection is in short supply. In Madhya Pradesh, Indore and Bhopal reported shortage of Remdesivir.

Long queues outside pharmacies were seen in Indore’s Dawa Bazar area for it. Sources said the MP government had ordered 20,000 vials of Remdesivir, but got only 2,000.

ALSO READ: Night curfew in 7 Karnataka cities from Saturday night

In Indore alone, the need is in the range of 5,000 to 7,000, but it received just 400 vials on Thursday. The state requires 10,000 to 13,000 vials daily.

As for Karnataka, while the official position was they were adequately stocked, sources said it is not available in most private hospitals and the drug is being sold on the black market for Rs 4,000.

However, Odisha, Kerala, Tamil Nadu, Telangana and Andhra Pradesh have reported thst they were comfortable with their Remedisivir stock position.

Black market

In Karnataka, sources said that the drug is not available in most private hospitals and is being sold on black market for Rs 4,000.

India Matters


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp